Company intelligence / Profile preview
Entos Pharmaceuticals
Edmonton, Alberta, Canadaentospharma.com ↗
- Ownership
- Private
- Employees
- ~70
- Development stage
- Preclinical
01
Overview
Entos has demonstrated strong preclinical results for its Fusogenix PLV platform in delivering nucleic acids safely and effectively. Its COVID‑19 DNA vaccine candidate completed Phase II trials with high immunogenicity and safety. The company is advancing gene therapies for rare genetic diseases such as congenital generalized lipodystrophy into IND-enabling studies, with additional oncology and neurology candidates progressing through preclinical development[6][9].
- Therapeutic areas
- OncologyRare DiseasesNeurologyInfectious Diseases
- Modalities
- Gene therapyDNA vaccinemRNA vaccineSmall molecule drug (in pipeline)Prophylactic vaccine[9][10]
- Industry
- Biotech
02
Drug pipeline
11 assets10 more assets in the full pipeline.
Request access →03
Partnerships
Eli Lilly & Co. – multi-program collaboration on PLV delivery of oligonucleotide therapeutics ($450M deal value)[3][4][10]BioMarin Pharmaceutical – agreement to use Fusogenix system for multiple genetic disease indications[10]OncoSenX – partnered on oncology gene therapies including OSX–001/OSX–002 [5]OISIN Biotechnologies – senolytic program partner [5]California Institute for Regenerative Medicine – funding support ($4M grant) [4]
Beyond the preview
Go deeper on Entos Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Entos Pharmaceuticals.